Axa’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,200
| Closed | -$118K | – | 1135 |
|
|
2023
Q3 | $118K | Sell |
13,200
-40,400
| -75% | -$361K | ﹤0.01% | 1039 |
|
|
2023
Q2 | $823K | Sell |
53,600
-299,187
| -85% | -$4.6M | ﹤0.01% | 868 |
|
|
2023
Q1 | $7.93M | Buy |
352,787
+81,575
| +30% | +$1.83M | 0.03% | 461 |
|
|
2022
Q4 | $5.7M | Sell |
271,212
-5,285
| -2% | -$111K | 0.02% | 559 |
|
|
2022
Q3 | $6.81M | Buy |
276,497
+46,407
| +20% | +$1.14M | 0.03% | 516 |
|
|
2022
Q2 | $5.58M | Buy |
230,090
+48,457
| +27% | +$1.17M | 0.02% | 553 |
|
|
2022
Q1 | $4.68M | Buy |
181,633
+160,233
| +749% | +$4.13M | 0.01% | 657 |
|
|
2021
Q4 | $664K | Buy |
+21,400
| New | +$664K | ﹤0.01% | 995 |
|
|
2021
Q3 | – | Sell |
-143,900
| Closed | -$2.1M | – | 1323 |
|
|
2021
Q2 | $2.1M | Sell |
143,900
-179,818
| -56% | -$2.62M | 0.01% | 879 |
|
|
2021
Q1 | $8.08M | Buy |
323,718
+133,518
| +70% | +$3.33M | 0.02% | 566 |
|
|
2020
Q4 | $5.18M | Hold |
190,200
| – | – | 0.02% | 686 |
|
|
2020
Q3 | $3.51M | Hold |
190,200
| – | – | 0.01% | 717 |
|
|
2020
Q2 | $3.88M | Sell |
190,200
-7,200
| -4% | -$147K | 0.02% | 686 |
|
|
2020
Q1 | $2.88M | Buy |
197,400
+32,000
| +19% | +$467K | 0.01% | 659 |
|
|
2019
Q4 | $2.35M | Hold |
165,400
| – | – | 0.01% | 779 |
|
|
2019
Q3 | $1.92M | Buy |
+165,400
| New | +$1.92M | 0.01% | 870 |
|
|
2016
Q1 | – | Sell |
-46,400
| Closed | -$895K | – | 1417 |
|
|
2015
Q4 | $895K | Buy |
46,400
+43,300
| +1,397% | +$835K | ﹤0.01% | 936 |
|
|
2015
Q3 | $63K | Buy |
+3,100
| New | +$63K | ﹤0.01% | 1340 |
|